John Robert Absher MD
Neuroimaging, Neuroimmunology/Multiple Sclerosis, Vascular Neurology, Dementia & Geriatrics
Clinical Professor USCSOMG; Director, Dementia and Neurobehavior Assessment Program; Medical Director ISC Brain Health Network
200 Patewood Dr.B-350Greenville, SC 29615
Fax+1 864-454-4505
Overview of Dr. Absher
Dr. John Absher is a neurologist in Greenville, SC, works as a neurohospitalist and stroke team member for Prisma Health-Upstate, and leads the Dementia and Neurobehavior Assessment Clinic, the Neuroimaging Research Core and the Summer Neuroimaging Research Program. He received his MD from Virginia Commonwealth University School of Medicine (MCV). He has faculty appointments at the USCSOM-Greenville and an adjunct faculty position at the Clemson University School of Health Research.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Behavioral Neurology, 1990 - 1992
University of Iowa Hospitals and ClinicsResidency, Neurology, 1987 - 1990
University of MarylandInternship, Internal Medicine, 1986 - 1987
Virginia Commonwealth University School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1990 - Present
NC State Medical License 2019 - 2027
SC State Medical License 1999 - 2027
TN State Medical License 2025 - 2027
IA State Medical License 1987 - 1991
American Board of Psychiatry and Neurology Neurology
American Society of NeuroimagingMRI/CT and Neurosonology- UCNSBehavioral Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2014, 2016-2017
- FAAN American Academy of Neurology, 2009
Clinical Trials
- Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy Start of enrollment: 2006 Jul 01
- Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase Start of enrollment: 2006 May 01
- Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- Harnessing team science in dementia research: Insights from the Alzheimer's disease research group in South Carolina.Sayema Akter, Eric Mishio Bawa, Nicholas Riccardi, Daniel A Amoatika, Margaret C Miller
Journal of Alzheimer's Disease Reports. 2025-10-16 - 1 citationsDementia Deaths Most Commonly Result from Heart and Lung Disease: Evidence from the South Carolina Alzheimer's Disease Registry.Daniel A Amoatika, John R Absher, Md Tareq Ferdous Khan, Maggi C Miller
Biomedicines. 2025-05-28 - Frontal damage and resolution of schizophrenia in a patient with self-inflicted gunshot wound: a case report.Shannon Smith, Mayanka Kumar, John Absher
BMC Neurology. 2025-02-24
Press Mentions
‘Weekend Warrior’ Exercise Can Cut Risk of Cognitive Decline, Study IndicatesOctober 29th, 2024
Quality Improvement in NeurologyMay 16th, 2017
Five Mentally Stimulating Activities Associated with a Lower Risk for Mild Cognitive ImpairmentMay 19th, 2016
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPOHealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
Humana ChoiceCare Network PPO
Medical Mutual of Ohio SuperMed Plus
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
